News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Daniel Flora: T-cell inhibition plus hypomethylation for locally advanced HER2-negative breast cancer
Daniel Flora/accru.org
Mar 5, 2025, 09:58

Daniel Flora: T-cell inhibition plus hypomethylation for locally advanced HER2-negative breast cancer

Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a paper he and his colleagues authored on LinkedIn:

“Thanks to St Elizabeth patients who participated in this clinical trial helping us find new ways to target breast cancer with immunotherapy. Also super cool to share authorship with my Emory University bud and rockstar oncologist Andrew Poklepovic.”

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Authors: Harry D Bear et al.

Daniel Flora: T-cell inhibition plus hypomethylation for locally advanced HER2-negative breast cancer

cancer Daniel Flora HER2-negative breast cancer OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 3, 2025, 00:40
THE LEAP trial at ASCO 2025 : Lenvatinib+pembrolizumab and chemotherapy vs.chemotherapy in a/mGEA
Oncolibrary
Jun 3, 2025, 00:22
Trial Updates at ASCO 2025: Neoadjuvant Pembrolizumab, Dabrafenib, and Trametinib in BRAF V600E-Mutated ATC
Blog
Jun 2, 2025, 18:21
Richard Lee: SIO Team Presented Real-World Implementation of ASCO-SIO Guidelines at ASCO25
Blog
Jun 2, 2025, 18:13
Chris Poulios: ASCO25 Sessions Include Patients' Perspective Along With Clinical and Laboratory-Focused Talks
Blog
Jun 2, 2025, 18:07
Sebastian Szmit: Right Ventricle in Patients With Cancer
Blog
Jun 2, 2025, 18:00
Shabnam Gujadhur: Day 2 at ASCO - Innovation, Insights, and Inspiration
Blog
Jun 2, 2025, 17:43
Gilberto Lopes Highlights Key Insights from Lung Oral Session at ASCO25
Blog
Jun 2, 2025, 17:33
Shivani Modi: Honored to Present Our Poster on Quantifying Financial Toxicity in Oncology at ASCO25
Blog
Jun 2, 2025, 17:18
Narjust Florez: Couldn’t Ask for a Better Partner as New IASLC Board Member
Blog
Jun 2, 2025, 17:06
Yüksel Ürün Highlights ML-integrated Biomarker Insights from CheckMate 9ER
Oncolibrary
Jun 2, 2025, 15:48
JAVELIN Bladder Medley Results: Avelumab + SG vs Avelumab in 1L Maintenance of Advanced UC
Blog
Jun 2, 2025, 15:40
Key Insights by Martin Zapata Laguado from ASCO25